Tarsus Pharmaceuticals, Inc.
TARS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001819790
In the last 90 days, Tarsus Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 256 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Tarsus Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- 0 vs. Q2 2021
- Shares held
- 12.9M
- −192.2K (−1.5%) vs. Q2 2021
- Total value
- $277.4M
- −$101.2M (−26.7%) vs. Q2 2021
- New holders
- 6
- 10 more added
- Sold out
- 6
- 16 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $2.98B |
| Q1 2026 | 253 | $3.17B |
| Q4 2025 | 246 | $3.61B |
| Q3 2025 | 220 | $2.67B |
| Q2 2025 | 205 | $1.87B |
| Q1 2025 | 195 | $2.26B |
| Q4 2024 | 195 | $2.23B |
| Q3 2024 | 162 | $1.43B |
| Q2 2024 | 148 | $1.09B |
| Q1 2024 | 157 | $1.43B |
| Q4 2023 | 116 | $652.0M |
| Q3 2023 | 105 | $529.4M |
| Q2 2023 | 92 | $387.3M |
| Q1 2023 | 74 | $252.1M |
| Q4 2022 | 69 | $301.0M |
| Q3 2022 | 75 | $350.8M |
| Q2 2022 | 73 | $291.7M |
| Q1 2022 | 51 | $222.2M |
| Q4 2021 | 43 | $294.2M |
| Q3 2021 | 44 | $277.4M |
| Q2 2021 | 44 | $378.5M |
| Q1 2021 | 41 | $410.4M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Tarsus Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tucker Asset Management LLC | 4 | $111 | 0.00% | 00.0% | Unchanged |
| American Portfolios Advisors | 39 | $840 | 0.00% | +39 | New |
| Parallel Advisors, LLC | 44 | $1.00K | 0.00% | +44 | New |
| Spire Wealth Management | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 200 | $4.00K | 0.00% | +200 | New |
| Tower Research Capital LLC (TRC) | 465 | $10.0K | 0.00% | −708−60.4% | Reduced |
| Ameritas Investment Partners, Inc. | 515 | $11.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 500 | $11.0K | 0.00% | +500 | New |
| Legal & General Group Plc | 818 | $18.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 925 | $20.0K | 0.00% | +348+60.3% | Added |
| Citigroup Inc | 962 | $21.0K | 0.00% | +561+139.9% | Added |
| STRS Ohio | 2,100 | $45.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,237 | $70.0K | 0.00% | −1,925−37.3% | Reduced |
| California State Teachers Retirement System | 4,520 | $97.0K | 0.00% | −7,124−61.2% | Reduced |
| American International Group, Inc. | 4,614 | $99.0K | 0.00% | −110−2.3% | Reduced |
| Deutsche Bank AG | 5,417 | $116.0K | 0.00% | −157−2.8% | Reduced |
| Bank of America Corp | 5,771 | $125.0K | 0.00% | +3,811+194.4% | Added |
| New York State Common Retirement Fund | 5,881 | $127.0K | 0.00% | −3,472−37.1% | Reduced |
| Virtus ETF Advisers LLC | 6,008 | $129.0K | 0.06% | −311−4.9% | Reduced |
| Wells Fargo & Company | 9,784 | $210.0K | 0.00% | +9,784 | New |
| J. Goldman & Co LP | 22,198 | $478.0K | 0.04% | −11,553−34.2% | Reduced |
| Nuveen Asset Management, LLC | 21,763 | $496.0K | 0.00% | −3,960−15.4% | Reduced |
| Bank of New York Mellon Corp | 24,523 | $529.0K | 0.00% | +2,950+13.7% | Added |
| Goldman Sachs Group Inc | 26,480 | $571.0K | 0.00% | −400−1.5% | Reduced |
| Morgan Stanley | 28,530 | $615.0K | 0.00% | +20,248+244.5% | Added |
| Invesco Ltd. | 28,614 | $616.0K | 0.00% | −1,814−6.0% | Reduced |
| SG Americas Securities, LLC | 46,253 | $997.0K | 0.01% | +23,276+101.3% | Added |
| Charles Schwab Investment Management Inc | 46,766 | $1.01M | 0.00% | +193+0.4% | Added |
| Northern Trust Corp | 74,011 | $1.59M | 0.00% | −5,624−7.1% | Reduced |
| Geode Capital Management, LLC | 123,698 | $2.67M | 0.00% | −1,823−1.5% | Reduced |
| State Street Corp | 126,802 | $2.73M | 0.00% | +7,661+6.4% | Added |
| Ghost Tree Capital, LLC | 170,000 | $3.66M | 1.21% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 200,000 | $4.31M | 0.01% | 00.0% | Unchanged |
| Sands Capital Ventures, LLC | 260,000 | $5.60M | 0.84% | +260,000 | New |
| Jefferies Group LLC | 422,993 | $9.12M | 0.22% | −20,000−4.5% | Reduced |
| Vanguard Group Inc | 428,990 | $9.24M | 0.00% | +2,945+0.7% | Added |
| BlackRock Inc. | 441,620 | $9.52M | 0.00% | +3,264+0.7% | Added |
| Cowen and Company, LLC | 514,289 | $11.1M | 0.53% | 00.0% | Unchanged |
| TimesSquare Capital Management, LLC | 650,780 | $14.0M | 0.12% | −35,925−5.2% | Reduced |
| Perceptive Advisors LLC | 1,296,416 | $27.9M | 0.41% | 00.0% | Unchanged |
| Frazier Management LLC | 1,417,157 | $30.5M | 2.44% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,444,831 | $31.1M | 1.27% | −69,438−4.6% | Reduced |
| RTW Investments, LP | 2,013,601 | $43.4M | 0.65% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,987,331 | $64.4M | 2.89% | 00.0% | Unchanged |
| Sands Capital Management, LLC | 0 | $0 | 0.00% | −260,000−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −70,573−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −16,686−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −8,600−100.0% | Sold out |
| Hunter Perkins Capital Management, LLC | 0 | $0 | 0.00% | −7,780−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |